advertisement

WGA Rescources

Selections from the Gullstrand Meeting

May 23-24, 2003, Uppsala, Sweden

Pamela Sample on Progression

  • Subjective judgment of serial visual fields is NOT reproducible
  • Two general approaches for judging progressionr Series analyses
    • series displays provided by perimeters
      • linear regression analysis
      • of global indices such as MD or PSD
      • point-by-point, such as Progressor
    • Single field visit analyzed relative to two reliable baseline visual fields
      • clinical trials scoring methods
      • glaucoma change probability
  • Currently, no single algorithm for identifying and quantifying progression in serial visual fields has gained wide acceptance
  • Confirmation reduces number of progressed eyes, e.g., EMGT progression: 49%; after first confirmation: 14%; after second confirmation: 8%
  • New approaches to assess progression: more sensitive test procedures, improved perimetric programs, modeling progression, Machine Learning Classifiers.
  • Machine Learning Classifiers:
    • are computer-based systems that learn from the data and develop their own classification algorithms
    • can be supervised or unsupervised learning
    • can learn complex patterns and trends in the data
    • can adapt to create decision surfaces without the constraints imposed by statistical classifiers
    • are unbiased and may identify meaningful patterns that experts may not see
  • Why is it so important to identify progression earlier?
    • treatment works; visual function is the ultimate test for success
    • prediction of progression not yet possible
    • shorter RCTs

Cristina Leske on Epidemiology:

  • in large studies, the prevalence of open-angle glaucoma in persons 40 years and older is:
    • -1%-3% in white populations
    • ->3%-9% in black populations
  • the incidence of glaucoma per year varies between 0.1% and 0.6% in large studies of persons 40 years and older
  • the 4 years incidence in the Barbados study was 0.7% at IOP <= 17 mmHg and 18.3% at IOP > 25 mmHg (25 times higher relative risk)
  • high IOP was a major risk factor but (Barbados study):
    1/4 OAG developed at IOP <= 13-19 mmHg
    1/2 OAG developed at IOP <= 21 mmHg
    2/3 OAG developed at IOP <= 25 mmHg
  • other risk factors: race, older age, higher IOP, lower perfusion pressure (blood pressure minus the IOP), family history, myopia; hypertension and diabetes are associated with higher IOP but not with OAG. future issues:
    • increase of prevalence (aging, global demographic changes e.g. Asia, Africa)
    • strategies to address modifiable and non-modifiable risk factors
    • glaucoma screening and natural history
  • future research:
    • standardized criteria for definitions
    • improved diagnostic methods
    • incidence and risk factors by race
    • gene-environment interactions
    • screening methods and effectiveness

Observations by Anja Tuulonen

  • In evidence-based studies 21% of visual fields were not eligible (mean of four OHT studies, including OHTS), 23% had no disc and retinal nerve fiber layer photos (mean of seven studies)
  • Profound experience is required for judging disc photographs, which may not be available in general ophthalmological practice
  • For confirmation of abnormality or progression, at least three visual fields (four RCTs) are needed with good reliability, same program, same instrument.
  • In OHTS, disc evaluation doubled the number of progressive cases; in EMGT, disc evaluation contributed little to overall progression. Why? (see Heijl in this issue of IGR)
  • Absolute risk reduction (ARR) in new progressive cases per year:
        treated untreated ARR OHTS 1% 2% 1% EMGT 8% 10% 2%

    The complete text of these three lectures will be available on a CD-rom to be issued by the Gullstrand organization.

    Issue 5-1

    Change Issue


    advertisement

    Nidek